Table 3. Inter-Group comparison of voiding parameters after treatment.
| Group 1 (n=34) | Group 2 (n=34) | p | |
|---|---|---|---|
| 24-hour frequency (Mean ± SD) | 7.7 ± 2.9 | 9.0 ± 3.1 | 0.078 |
| Average voided volume, mL (Mean ± SD) | 261.7 ± 77.5 | 258.0 ± 82.0 | 0.850 |
| Qmax, mL/s, (Mean ± SD) | 14.8 ± 2.6 | 12.8 ± 2.9 | 0.026 |
| Qave, mL/s (Mean ± SD) | 8.0 ± 1.0 | 6.7 ± 1.1 | 0.043 |
| PVR, mL (Mean ± SD) | 54.7 ± 31.5 | 65.7 ± 24.1 | 0.023 |
| UDI-6 score (Median) | 9 | 12 | 0.034 |
| EMG activity, n (%) | 14 (41.2) | 22 (64.7) | 0.009 † |
Qmax = maximum urine flow rate; Qave = average urine flow rate; PVR = Post-void residual urine volume; UDI-6 = Urogenital Distress Inventory; EMG = electromyography
†
Intergroup comparison was performed using the Chi-square test